Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-09

FDA Approved: TELMISARTAN — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for TELMISARTAN from Aurobindo Pharma Limited, authorizing a generic telmisartan product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan (Telmisartan)

Snippet

SUPPL AP for TELMISARTAN (TELMISARTAN)